Top Markets
Coin of the day
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

BLCM
Rank in Stocks #38880
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage... Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lymphomas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.
Share Price
$0.07475
Last synced: 2024-03-04
Market Cap
$755.60K
Change (1 day)
-6.68%
Change (1 year)
0.00%
Country
US
Trade Bellicum Pharmaceuticals, Inc. (BLCM)

Category

Stock price history for Bellicum Pharmaceuticals, Inc. (BLCM)
Highest end of day price: $0.08 on 2024-03-01

Lowest end of day price: $214.46 on 2014-12-01
Stock price history of Bellicum Pharmaceuticals, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2024 -58.98%
2023 -77.47%
2022 -48.69%
2021 -48.79%
2020 -67.81%
2019 -72.37%
2018 -59.58%
2017 -43.00%
2016 -22.19%
2015 -6.78%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$507.30 29.98%
US
$845.59 29.61%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE